Clinical trials often analyze and report outcomes from ideal settings where sites
and investigators are deliberately selected, and patients have met stringent requirements
to participate. These outcomes may not be seen in clinical settings. We report the
initial “real-world” experience with vBloc therapy in a cohort of patients with severe
obesity in 14 centers across the U.S., including surgeries performed at a VA hospital.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgery for Obesity and Related DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.
